Literature DB >> 15033855

Hypercalcaemia in infancy; a presenting feature of spinal muscular atrophy.

K Khawaja1, W T Houlsby, S Watson, K Bushby, T Cheetham.   

Abstract

A 10 month old girl presented with a history of constipation from early life. She was found to be hypercalcaemic with hypercalciuria and nephrocalcinosis. Her mild motor delay and hypotonia were thought to be linked to chronic hypercalcaemia, but when these features failed to improve despite normocalcaemia on a low calcium diet the possibility of neuromuscular disease was explored in more detail. She was subsequently found to have spinal muscular atrophy type 2. We suspect that the hypercalcaemia with hypercalciuria observed in this case reflects altered bone turnover secondary to reduced muscular activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033855      PMCID: PMC1719875          DOI: 10.1136/adc.2003.028225

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

Review 1.  Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling.

Authors:  Srinivasan Shanmugarajan; Kathryn J Swoboda; Susan T Iannaccone; William L Ries; Bernard L Maria; Sakamuri V Reddy
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

2.  Vitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone health.

Authors:  Jennifer Aton; Rebecca Hurst Davis; Kristine C Jordan; Charles B Scott; Kathryn J Swoboda
Journal:  J Child Neurol       Date:  2013-01-17       Impact factor: 1.987

Review 3.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

4.  Observational study of caloric and nutrient intake, bone density, and body composition in infants and children with spinal muscular atrophy type I.

Authors:  Katherine E Poruk; Rebecca Hurst Davis; Abby L Smart; Benjamin S Chisum; Bernie A Lasalle; Gary M Chan; Gurmail Gill; Sandra P Reyna; Kathryn J Swoboda
Journal:  Neuromuscul Disord       Date:  2012-07-23       Impact factor: 4.296

5.  Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy.

Authors:  Srinivasan Shanmugarajan; Eichi Tsuruga; Kathryn J Swoboda; Bernard L Maria; William L Ries; Sakamuri V Reddy
Journal:  J Pathol       Date:  2009-09       Impact factor: 7.996

Review 6.  Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes.

Authors:  Natalia N Singh; Shaine Hoffman; Prabhakara P Reddi; Ravindra N Singh
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-05       Impact factor: 5.187

Review 7.  The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

Authors:  James N Sleigh; Thomas H Gillingwater; Kevin Talbot
Journal:  Dis Model Mech       Date:  2011-07       Impact factor: 5.758

8.  An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy.

Authors:  Chung-Wei Yang; Chien-Lin Chen; Wei-Chun Chou; Ho-Chen Lin; Yuh-Jyh Jong; Li-Kai Tsai; Chun-Yu Chuang
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.